David G Kirsch Selected Research

Sarcoma (Soft Tissue Sarcoma)

7/2022	13C tracer analysis suggests extensive recycling of endogenous CO2 in vivo.
1/2022	Comparison of 3D Conformal Proton Therapy, Intensity-Modulated Proton Therapy, and Intensity-Modulated Photon Therapy for Retroperitoneal Sarcoma.
1/2022	Extent of tumor fibrosis/hyalinization and infarction following neoadjuvant radiation therapy is associated with improved survival in patients with soft-tissue sarcoma.
11/2021	Tumor-propagating side population cells are a dynamic subpopulation in undifferentiated pleomorphic sarcoma.
10/2021	Radiation-Induced Phosphorylation of a Prion-Like Domain Regulates Transformation by FUS-CHOP.
1/2021	Preoperative radiotherapy for retroperitoneal sarcoma.
1/2021	Ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities.
12/2020	Single cell analysis reveals distinct immune landscapes in transplant and primary sarcomas that determine response or resistance to immunotherapy.
11/2020	Response to Central Boost Radiation Therapy in an Unresectable Retroperitoneal Sarcoma: A Case Report.
10/2020	The Long Noncoding RNA NEAT1 Promotes Sarcoma Metastasis by Regulating RNA Splicing Pathways.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David G Kirsch Research Topics

Disease

101	Neoplasms (Cancer) 07/2022 - 01/2004
67	Sarcoma (Soft Tissue Sarcoma) 07/2022 - 04/2007
13	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2013
10	Carcinogenesis 10/2021 - 01/2012
9	Lung Neoplasms (Lung Cancer) 01/2022 - 07/2005
7	Brain Neoplasms (Brain Tumor) 01/2021 - 01/2004
6	Breast Neoplasms (Breast Cancer) 01/2021 - 03/2005
5	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2022 - 08/2014
5	Acute Radiation Syndrome 12/2021 - 05/2014
5	Hypoxia (Hypoxemia) 01/2019 - 10/2013
4	COVID-19 12/2020 - 01/2020
4	Neurofibrosarcoma (MPNST) 01/2020 - 10/2012
3	Uveal melanoma 03/2022 - 05/2014
3	Glioma (Gliomas) 01/2022 - 01/2013
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 03/2010
3	Myxoid Liposarcoma 10/2021 - 01/2019
3	Adenocarcinoma of Lung 01/2021 - 10/2005
3	Melanoma (Melanoma, Malignant) 06/2020 - 01/2018
3	Margins of Excision 01/2019 - 07/2010
3	Radiation Injuries (Radiation Sickness) 01/2019 - 03/2013
3	Residual Neoplasm 01/2016 - 10/2015
2	Genetic Translocation (Chromosomal Translocation) 10/2021 - 11/2013
2	Diffuse Intrinsic Pontine Glioma 01/2021 - 01/2013
2	Lymphoma (Lymphomas) 01/2021 - 09/2015
2	Wounds and Injuries (Trauma) 10/2016 - 07/2013
2	Rhabdomyosarcoma 12/2013 - 01/2012
1	Infarction (Infarctions) 01/2022
1	Heart Failure 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Necrosis 01/2022
1	Paralysis (Palsy) 11/2021
1	Spinal Cord Diseases 11/2021
1	Atherosclerosis 01/2021
1	Cardiotoxicity 01/2021
1	Chordoma 06/2020

Drug/Important Bio-Agent (IBA)

10	Recombinases (Recombinase)IBA 01/2022 - 05/2012
8	MicroRNAs (MicroRNA)IBA 01/2022 - 12/2009
8	Biological ProductsIBA 01/2021 - 11/2014
7	Phosphotransferases (Kinase)IBA 01/2022 - 01/2012
7	Cre recombinaseIBA 10/2020 - 08/2007
7	Peptide Hydrolases (Proteases)FDA Link 08/2016 - 10/2005
7	Contrast MediaIBA 10/2015 - 01/2012
6	Pharmaceutical PreparationsIBA 12/2021 - 01/2013
6	IodineIBA 01/2018 - 01/2012
5	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 03/2015
5	RNA (Ribonucleic Acid)IBA 01/2021 - 12/2013
5	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 01/2012
5	Protons (Proton)IBA 01/2018 - 05/2004
5	Small Interfering RNA (siRNA)IBA 07/2017 - 05/2013
5	Fluorescent Dyes (Fluorescent Probes)IBA 01/2016 - 11/2012
4	Iodine-125IBA 03/2022 - 05/2014
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2005
4	Proteins (Proteins, Gene)FDA Link 10/2021 - 05/2014
4	GoldIBA 01/2018 - 03/2013
4	CathepsinsIBA 05/2013 - 10/2005
3	dipinacoline glutamateIBA 01/2022 - 01/2013
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2018 - 05/2013
3	EnzymesIBA 01/2016 - 10/2013
3	Trastuzumab (Herceptin)FDA Link 04/2008 - 03/2005
2	Glucose (Dextrose)FDA LinkGeneric 07/2022 - 01/2021
2	Oncogene Proteins (Oncogene Protein)IBA 10/2021 - 01/2019
2	Immune Checkpoint InhibitorsIBA 12/2020 - 10/2018
2	Glycogen Synthase (Synthase I)IBA 01/2020 - 05/2014
2	CarbonIBA 01/2019 - 01/2018
2	IonsIBA 01/2018 - 07/2016
2	CateninsIBA 01/2016 - 09/2014
2	Acridine OrangeIBA 01/2016 - 01/2013
2	AcriflavineIBA 11/2015 - 01/2013
2	dactolisibIBA 03/2015 - 01/2012
2	GadoliniumIBA 06/2013 - 07/2010
1	Glutamine (L-Glutamine)FDA Link 07/2022
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2022
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2022
1	Interleukin-2 (IL2)IBA 01/2022
1	CaspasesIBA 12/2021
1	InflammasomesIBA 12/2021
1	Diphtheria ToxinIBA 11/2021
1	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 11/2021
1	Glial Fibrillary Acidic ProteinIBA 11/2021
1	PrionsIBA 10/2021
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2021
1	Apolipoproteins E (ApoE)IBA 01/2021
1	ApolipoproteinsIBA 01/2021
1	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 12/2020
1	Long Noncoding RNAIBA 10/2020
1	Peptides (Polypeptides)IBA 01/2020

Therapy/Procedure

70	Radiotherapy 01/2022 - 01/2004
33	Therapeutics 01/2022 - 02/2007
6	Neoadjuvant Therapy 01/2022 - 11/2011
6	Drug Therapy (Chemotherapy) 01/2020 - 11/2004
5	Brachytherapy 03/2022 - 07/2016
4	Proton Therapy 01/2022 - 01/2004
4	Immunotherapy 12/2020 - 01/2018
3	Aftercare (After-Treatment) 02/2019 - 07/2009
2	Surgical Amputation (Amputations) 10/2020 - 10/2014
2	Chemoradiotherapy 10/2019 - 01/2016
2	Adjuvant Radiotherapy 10/2016 - 07/2013
2	Image-Guided Radiotherapy 07/2016 - 07/2015
2	Transplantation 08/2015 - 01/2015
1	Re-Irradiation 06/2020